Synedgen, Inc. of CLAREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-10-20. The offering totals $4.0M, of which $995K was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| John Morgan | Director | Shelby Township, MI |
| Keiki-Pua Dancil | Executive Officer | Claremont, CA |
| Clarke Atwell | Director | Half Moon Bay, CA |
| Andrew Miller | Director | Durham, NC |
| Paul Grint | Director | San Diego, CA |
| Shenda Baker | Director | Claremont, CA |
| Shenda Baker | Executive Officer | Claremont, CA |
| William P Wiesmann | Director | Claremont, CA |
| William P Wiesmann | Executive Officer | Claremont, CA |
| Paul C Grint | Director | Claremont, CA |
| Hal W Oien | Director | Claremont, CA |
| Andrew W Miller | Director | Claremont, CA |
| Daniel C Bradbury | Director | Claremont, CA |
| Kaveri P Parker | Executive Officer | Claremont, CA |
| Kenton P Gregory | Director | Claremont, CA |
| Diane Olmstead | Director | SALT LAKE CITY, UT |
| Kenton Gregory | Director | Wilsonville, OR |
| William P Wiesmann, M.D. | Director | Claremont, CA |
| William P Wiesmann, M.D. | Executive Officer | Claremont, CA |
| Kenton P Gregory, M.D. | Director | Claremont, CA |
| Paul P Grint, M.D. | Director | Claremont, CA |
| Kenton W Gregory, M.D. | Director | Claremont, CA |
| Robert P Coughlin | Director | Claremont, CA |
| Robert Coughlin | Director | San Jose, CA |
| William Weismann | Director | Claremont, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-10-01 | D | $2.0M | $1.8M |
| 2019-07-12 | D | $3.0M | $2.5M |
| 2017-09-12 | D | $3.0M | $3.0M |
| 2016-11-08 | D | $3.5M | $3.0M |
| 2016-04-27 | D | $6.5M | $6.0M |
| 2015-03-03 | D | $4.0M | $3.5M |
| 2014-08-13 | D | $607K | $607K |
| 2013-07-12 | D/A | $4.0M | $4.0M |
| 2013-04-29 | D/A | $4.0M | $3.2M |
| 2012-05-14 | D/A | $4.0M | $2.5M |
| 2012-05-14 | D/A | $4.0M | $2.5M |
| 2012-05-14 | D/A | $4.0M | $2.5M |
| 2012-05-14 | D/A | $4.0M | $2.5M |
| 2011-09-14 | D/A | $4.0M | $2.1M |